Overall, the final outcome of HSP+ exosomes on NK cell anti-tumor immune response depends on a direct stimulatory effect on these cytotoxic lymphocytes and/or on the different subset of immune cells localized in the tumor microenvironment and responsive to HSPs (Figure 1b). The gene discussed is HSP90B2P; the disease is neoplasm.